Menu
Back to Journals » Cancer Management and Research » Volume 14
Original Research
Considerations for the Utility of Real-World Evidence Beyond Trial Data in Advanced NSCLC: The Case of Frontline Tyrosine Kinase Inhibitors
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,554 | Dovepress* | 3,372+ | 97 | 3,469 | |
| PubMed Central* | 182 | 72 | 254 | ||
| Totals | 3,554 | 169 | 3,723 | ||
| *Since 7 December 2022 | |||||
View citations on PubMed Central and Google Scholar